Practical outpatient management of worsening chronic heart failure.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
05 2022
Historique:
revised: 04 04 2022
received: 05 10 2021
accepted: 10 04 2022
pubmed: 14 4 2022
medline: 24 5 2022
entrez: 13 4 2022
Statut: ppublish

Résumé

Management of worsening heart failure (WHF) has traditionally been hospital-based, but with the rising burden of heart failure (HF), the pressure on healthcare systems exerted by this disease necessitates a different strategy than long (and costly) hospital stays. A strategy for outpatient intravenous (IV) diuretic treatment of WHF has been developed in certain American centres in the past 10 years, whereas European centres have been mostly favouring 'classic' in-hospital management of WHF. Embracing novel, outpatient approaches for treating WHF could substantially reduce the burden on healthcare systems while improving patient's satisfaction and quality of life. The present article is intended to provide essential knowledge and practical guidelines aimed at helping clinicians implement these new ambulatory approaches using day hospital and/or at-home hospitalization. The topics addressed by our group of HF experts include the pathophysiological background of diuretic therapy, the most suitable profile of WHF that may be managed in an ambulatory setting, the pharmacological protocols that can be used, as well as a detailed description of healthcare structures that can be proposed to deliver these ambulatory care interventions. The practical aspects of day hospital and hospital-at-home IV diuretic administration are specifically emphasized. The algorithm provided along with the practical IV diuretic protocols should assist HF clinicians in implementing this new approach in their local clinical setting.

Identifiants

pubmed: 35417093
doi: 10.1002/ejhf.2503
pmc: PMC9325366
doi:

Substances chimiques

Diuretics 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

750-761

Informations de copyright

© 2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Acta Cardiol. 2019 Apr;74(2):100-107
pubmed: 29587582
Eur J Heart Fail. 2009 Dec;11(12):1208-13
pubmed: 19875400
Nat Med. 2022 Mar;28(3):568-574
pubmed: 35228754
JAMA Cardiol. 2018 Mar 1;3(3):252-259
pubmed: 29387880
N Engl J Med. 2005 Dec 29;353(26):2788-96
pubmed: 16382065
Circ Heart Fail. 2021 Jul;14(7):e008212
pubmed: 34247518
Eur J Intern Med. 2014 Jan;25(1):67-72
pubmed: 24070521
Am Heart J. 2021 Mar;233:122-131
pubmed: 33352187
Arch Cardiovasc Dis. 2020 Oct;113(10):660-670
pubmed: 32660835
Lancet. 2019 Mar 9;393(10175):1034-1044
pubmed: 30860029
Eur J Heart Fail. 2010 May;12(5):423-33
pubmed: 20354029
N Engl J Med. 2019 Feb 7;380(6):539-548
pubmed: 30415601
ESC Heart Fail. 2020 Jun;7(3):892-902
pubmed: 32159279
J Eval Clin Pract. 2020 Jun;26(3):842-851
pubmed: 31436024
Rev Esp Cardiol (Engl Ed). 2017 Aug;70(8):631-638
pubmed: 28215922
Eur Heart J. 2006 Nov;27(22):2725-36
pubmed: 17000631
JACC Heart Fail. 2013 Feb;1(1):1-20
pubmed: 24621794
Eur J Heart Fail. 2016 Dec;18(12):1411-1414
pubmed: 27612005
Eur J Heart Fail. 2021 May;23(5):729-739
pubmed: 33190378
Cardiovasc Drugs Ther. 2016 Dec;30(6):599-609
pubmed: 27819111
Br Heart J. 1994 Aug;72(2 Suppl):S40-3
pubmed: 7946757
JAMA Cardiol. 2021 May 1;6(5):499-507
pubmed: 33595593
Eur J Heart Fail. 2017 Nov;19(11):1427-1443
pubmed: 28233442
Cardiovasc Ther. 2018 Dec;36(6):e12465
pubmed: 30191652
Eur J Heart Fail. 2017 Jul;19(7):821-836
pubmed: 28560717
J Am Coll Cardiol. 2003 Aug 20;42(4):705-8
pubmed: 12932605
Eur J Heart Fail. 2019 Mar;21(3):337-341
pubmed: 30741494
Heart. 2018 Mar;104(5):377-384
pubmed: 29305560
JAMA Cardiol. 2017 Sep 1;2(9):950-958
pubmed: 28700781
N Engl J Med. 2011 Mar 3;364(9):797-805
pubmed: 21366472
Eur J Heart Fail. 2019 Feb;21(2):137-155
pubmed: 30600580
J Card Fail. 2020 Sep;26(9):798-799
pubmed: 31704197
PLoS One. 2015 Jun 08;10(6):e0129282
pubmed: 26052944
JACC Basic Transl Sci. 2018 Feb 07;3(1):25-34
pubmed: 30062191
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Clin Res Cardiol. 2019 Nov;108(11):1240-1248
pubmed: 30895374
Lancet. 2020 Sep 19;396(10254):819-829
pubmed: 32877652
J Card Fail. 2008 Jun;14(5):388-93
pubmed: 18514930
Eur J Heart Fail. 2018 Apr;20(4):738-747
pubmed: 29251818
J Card Fail. 2022 Feb 16;:
pubmed: 35181553
J Am Coll Cardiol. 2020 Mar 17;75(10):1178-1195
pubmed: 32164892
ESC Heart Fail. 2021 Oct;8(5):3906-3916
pubmed: 34382749
JAMA. 2019 Sep 17;322(11):1085-1095
pubmed: 31475295
J Am Heart Assoc. 2020 Jul 21;9(14):e016010
pubmed: 32662300
J Am Coll Cardiol. 2016 Jul 19;68(3):241-248
pubmed: 27417000
Public Health Rep. 2011 Jul-Aug;126(4):460-71
pubmed: 21800741
Circulation. 2015 Jan 6;131(1):54-61
pubmed: 25403646
Eur J Heart Fail. 2021 May;23(5):703-712
pubmed: 33118672
Cardiorenal Med. 2017 Feb;7(2):137-149
pubmed: 28611787
N Engl J Med. 2021 Jan 14;384(2):117-128
pubmed: 33200892
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
J Am Soc Hypertens. 2012 Sep-Oct;6(5):299-308
pubmed: 22951101
Circulation. 2021 Apr 27;143(17):1673-1686
pubmed: 33550815
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Eur J Heart Fail. 2016 Mar;18(3):242-52
pubmed: 26727047
Eur J Heart Fail. 2020 Jun;22(6):995-998
pubmed: 32385954
Lancet. 2011 Feb 19;377(9766):658-66
pubmed: 21315441
JACC Heart Fail. 2016 Jan;4(1):1-8
pubmed: 26656139
Nat Rev Cardiol. 2020 Oct;17(10):641-655
pubmed: 32415147
Am Heart J. 2021 Feb;232:116-124
pubmed: 33144086
Circ Heart Fail. 2020 May;13(5):e006597
pubmed: 32354280
JACC Heart Fail. 2021 May;9(5):374-382
pubmed: 33839075
Circulation. 2020 Nov 3;142(18):1713-1724
pubmed: 32865004
Circulation. 2020 Sep 15;142(11):1028-1039
pubmed: 32410463
Eur J Heart Fail. 2020 Aug;22(8):1357-1365
pubmed: 32353213
Am Heart J. 2002 Jul;144(1):31-8
pubmed: 12094185
Eur J Heart Fail. 2013 Jul;15(7):808-17
pubmed: 23537547
Int Heart J. 2021 Jan 30;62(1):193-196
pubmed: 33455988
Curr Cardiol Rev. 2015;11(1):80-9
pubmed: 24251462
JACC Heart Fail. 2018 Apr;6(4):273-285
pubmed: 29226815
Am J Med. 2015 Jul;128(7):776-83.e4
pubmed: 25595470
Hypertension. 2017 Jan;69(1):32-41
pubmed: 27849566
J Clin Med Res. 2021 Apr;13(4):245-251
pubmed: 34007363
Circ Heart Fail. 2016 May;9(5):
pubmed: 27140204
Eur J Heart Fail. 2020 Aug;22(8):1342-1356
pubmed: 32483830
Circulation. 2020 Sep 15;142(11):1040-1054
pubmed: 32673497

Auteurs

Nicolas Girerd (N)

Centre d'Investigation Clinique- Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Université de Lorraine, Nancy, France.

Nathan Mewton (N)

Hôpital Cardiovasculaire Louis Pradel Hospices Civils de Lyon Heart Failure Department Clinical Investigation Center Inserm 1407 CarMeN Inserm 1060, University Claude Bernard Lyon, Bron, France.

Jean-Michel Tartière (JM)

CHITS, Department of Cardiology, Hôpital Sainte-Musse, Toulon, France.

Damien Guijarro (D)

CHU Nantes, CNRS, INSERM, l'institut Du Thorax, Université de Nantes, Nantes, France.

Patrick Jourdain (P)

Covidom Regional Telemedicine Platform, Assistance Publique-Hôpitaux de Paris, Paris, France.
Cardiology Department, University Hospital of Bicêtre, Assistance Publique-Hôpitaux de Paris, Kremlin Bicêtre, France.

Thibaud Damy (T)

Réseau Cardiogen, Department of Cardiology, Centre Français de Référence de l'Amylose Cardiaque (CRAC), CHU d'Henri-Mondor, Créteil, France.

Nicolas Lamblin (N)

Department of Cardiology, CHU de Lille, Université de Lille, Lille, France.

Antoni Bayes-Génis (A)

CIBERCV, Servicio de Cardiología, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.

Pierpaolo Pellicori (P)

Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

James L Januzzi (JL)

Cardiology Division, Massachusetts General Hospital, Baim Institute for Clinical Research, Harvard Medical School, Boston, MA, USA.

Patrick Rossignol (P)

Centre d'Investigation Clinique- Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Université de Lorraine, Nancy, France.

François Roubille (F)

PhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, CHU de Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH